Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Transfer of Validated Method to QC – V 2.0

Posted on By

Analytical Method Development: SOP for Transfer of Validated Method to QC – V 2.0

Standard Operating Procedure for Transferring Validated Analytical Methods to Quality Control


Department Analytical Method Development
SOP No. SOP/AMD/208/2025
Supersedes SOP/AMD/208/2022
Page No. Page 1 of 14
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP outlines the procedure for the formal transfer of validated analytical methods from the Analytical Method Development (AMD) department to the Quality Control (QC) department. The goal is to ensure that

the method performs reliably under routine laboratory conditions and complies with GMP and ICH Q14/Q2(R2) guidelines.

2. Scope

This SOP is applicable to all validated analytical methods developed for drug substances, drug products, raw materials, and intermediates that are to be implemented in the Quality Control laboratory.

3. Responsibilities

  • AMD Analyst: Prepares and shares method transfer documentation and reference standards.
  • QC Analyst: Executes transfer verification runs and records observations.
  • AMD/QC Group Leaders: Coordinate and supervise the transfer activity.
  • QA Executive: Reviews transfer protocol and report; approves final documentation.
See also  Analytical Method Development: Limit Test for Chloride/Sulphate Development - V 2.0

4. Accountability

The Heads of Analytical Method Development and Quality Control are jointly accountable for the successful execution and documentation of method transfer activities.

5. Procedure

5.1 Pre-Transfer Review

  1. Confirm that the method is fully validated as per ICH Q2(R1) or Q14 requirements.
  2. Ensure the following documents are ready:
    • Method of analysis (MoA)
    • Validation report
    • Standard operating procedures
    • Reference standards and sample materials

5.2 Method Transfer Planning

  1. Prepare a Method Transfer Protocol including:
    • Transfer approach: Comparative testing or co-validation
    • Number of replicates, acceptance criteria, instruments to be used
    • List of materials, batch numbers, analysts, timelines
  2. Get the protocol reviewed by QA and approved prior to execution.

5.3 Execution of Transfer

  1. Conduct testing in AMD and QC labs in parallel or sequentially.
  2. Perform at least 6 replicate sample and standard analyses at both sites.
  3. Compare the following parameters:
    • % Assay values
    • % RSD of replicate injections
    • System suitability criteria (RT, Rs, N, T)
  4. Document all observations in Annexure-1 and Annexure-2.
See also  Analytical Method Development: SOP for Documentation of Analytical Calculations and Worksheets - V 2.0

5.4 Data Evaluation

  1. Evaluate transfer success based on:
    • Difference in assay between labs ≤ 2.0%
    • System suitability passed
    • Acceptance criteria met for all key parameters
  2. Summarize results in Annexure-3: Method Transfer Summary Report.

5.5 Post-Transfer Steps

  1. QA to review and approve the report.
  2. Update SOPs in QC lab with the transferred method.
  3. Train QC analysts and file training records.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • AMD: Analytical Method Development
  • QA: Quality Assurance
  • MoA: Method of Analysis

7. Documents

  1. Inter-Laboratory Data Sheet – Annexure-1
  2. System Suitability Log – Annexure-2
  3. Method Transfer Summary Report – Annexure-3

8. References

  • ICH Q14: Analytical Procedure Development
  • ICH Q2(R2): Analytical Procedure Validation
  • GMP Guidelines – Schedule M (India)
See also  Analytical Method Development: Specificity Testing by FTIR - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Meenal Deshmukh Vikas Trivedi Sunita Reddy
Designation Method Transfer Chemist QA Reviewer Department Head
Department AMD QA Analytical Method Development

11. Annexures

Annexure-1: Inter-Laboratory Data Sheet

Parameter AMD Lab QC Lab Difference Status
% Assay 98.9% 99.2% 0.3% Pass
% RSD 0.7% 0.6% – Pass

Annexure-2: System Suitability Log

Lab RT Resolution Theoretical Plates Status
AMD 5.2 2.5 3200 Pass
QC 5.1 2.4 3100 Pass

Annexure-3: Method Transfer Summary Report

Method Title Assay of Levofloxacin
Transfer Date 18/05/2025
Transfer Type Comparative Testing
Transfer Status Successful
Remarks All parameters within acceptable range

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Aligned with ICH Q14 Annual Update Sunita Reddy
10/02/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Audit Gap: SOPs Not Aligned With Validated Cleaning Cycles
Next Post: Manufacturing Operations: SOP for Prefilled Syringe Assembly Line Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version